Woodside Energy Group Ltd
WDS
Westpac Banking Corp
WBC
Telstra Group Ltd
TLS
4
Rio Tinto Ltd
RIO
5
Origin Energy Ltd
ORG
AU Stock MarketDetailed Quotes
DXB Dimerix Ltd
- 0.470
- 0.0000.00%
20min DelayMarket to Open Mar 17 16:00 AET
262.75MMarket Cap-12.37P/E (Static)
0.000High0.000Low0Volume0.000Open0.470Pre Close0.00Turnover0.66552wk High0.00%Turnover Ratio559.04MShares0.27552wk Low-0.045EPS TTM205.66MFloat Cap146582.030Historical HighLossP/E (Static)437.57MShs Float0.052Historical Low-0.038EPS LYR0.00%Amplitude--Dividend TTM36.15P/B1Lot Size--Div YieldTTM
About Dimerix Ltd Company
Dimerix Ltd is a biopharmaceutical company developing new therapies in areas with unmet medical needs. The company is developing four product candidates: DMX-200 for FSGS; DMX-200 for diabetic kidney disease; DMX-200 for ARDS associated with COVID-19; and DMX-700 for COPD; as well as the proprietary ReceptorHIT assay technology.
Company Profile
SymbolDXB
Company NameDimerix Ltd
Founded1975
MarketASX
Employees12
Fiscal Year Ends06-30
Address425 Smith Street
CityFitzroy
CountryAustralia
Zip Code3065
Phone+61 1300813321
Websitehttps://www.dimerix.com
Share RegistryAUTOMIC REGISTRY SERVICES
Level 5, 126 Phillip Street, SYDNEY, NSW, AUSTRALIA, 2000
02 9698 5414
Company Executives
- Name
- Position
- Salary
- Nina Webster
- Chief Executive Officer,Managing Director
- --
- Sonia Maria Poli
- Non-Executive Director
- --
- Mark P Diamond
- Non-Executive Director
- --
- Hugh Alsop
- Non-Executive Director
- --
- Clinton Snow
- Non-Executive Director
- --